These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38194774)
1. A potent GPX4 degrader to induce ferroptosis in HT1080 cells. Song H; Liang J; Guo Y; Liu Y; Sa K; Yan G; Xu W; Xu W; Chen L; Li H Eur J Med Chem; 2024 Feb; 265():116110. PubMed ID: 38194774 [TBL] [Abstract][Full Text] [Related]
2. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect. Wang C; Zheng C; Wang H; Shui S; Jin H; Liu G; Xu F; Liu Z; Zhang L; Sun D; Xu P Eur J Med Chem; 2023 Feb; 247():115072. PubMed ID: 36603510 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags. Ning Y; Zhu Z; Wang Y; Fan X; Wang J; Qian H; Qiu X; Wang Y Eur J Med Chem; 2024 Nov; 277():116719. PubMed ID: 39094276 [TBL] [Abstract][Full Text] [Related]
4. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells. Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. Cai M; Ma F; Hu C; Li H; Cao F; Li Y; Dong J; Qin JJ Bioorg Med Chem; 2023 Jul; 90():117352. PubMed ID: 37257255 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization. Zheng C; Wang C; Sun D; Wang H; Li B; Liu G; Liu Z; Zhang L; Xu P Eur J Med Chem; 2023 Jul; 255():115393. PubMed ID: 37098297 [TBL] [Abstract][Full Text] [Related]
7. Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4. Zhu L; Hu S; Yan X; Zeng Q; Zhang B; Jiang L; Yao SQ; Ge J Bioorg Chem; 2023 May; 134():106461. PubMed ID: 36924654 [TBL] [Abstract][Full Text] [Related]
8. Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis. Dong J; Ma F; Cai M; Cao F; Li H; Liang H; Li Y; Ding G; Li J; Cheng X; Qin JJ J Med Chem; 2024 Sep; 67(18):16712-16736. PubMed ID: 39230973 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer. Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders. Li X; Hu M; Zhang Y; Hua H; Sun Y; Xiang Q; Zhu D Bioorg Chem; 2024 Mar; 144():107115. PubMed ID: 38232684 [TBL] [Abstract][Full Text] [Related]
11. Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges. Liu J; Tang D; Kang R Trends Pharmacol Sci; 2024 Aug; 45(8):666-670. PubMed ID: 38866667 [TBL] [Abstract][Full Text] [Related]
13. ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells. Hu M; Li X; Wang L; Zhang Y; Sun Y; Hua H; Liu H; Cai T; Zhu D; Xiang Q ACS Med Chem Lett; 2024 Mar; 15(3):406-412. PubMed ID: 38505849 [TBL] [Abstract][Full Text] [Related]
14. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy. Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε. Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313 [TBL] [Abstract][Full Text] [Related]
16. Dauricine alleviated secondary brain injury after intracerebral hemorrhage by upregulating GPX4 expression and inhibiting ferroptosis of nerve cells. Peng C; Fu X; Wang K; Chen L; Luo B; Huang N; Luo Y; Chen W Eur J Pharmacol; 2022 Jan; 914():174461. PubMed ID: 34469757 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer. Xu C; Xiao Z; Wang J; Lai H; Zhang T; Guan Z; Xia M; Chen M; Ren L; He Y; Gao Y; Zhao C J Med Chem; 2021 Sep; 64(18):13312-13326. PubMed ID: 34506134 [TBL] [Abstract][Full Text] [Related]
18. Research progress on GPX4 targeted compounds. Li B; Cheng K; Wang T; Peng X; Xu P; Liu G; Xue D; Jiao N; Wang C Eur J Med Chem; 2024 Aug; 274():116548. PubMed ID: 38838547 [TBL] [Abstract][Full Text] [Related]
19. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597 [TBL] [Abstract][Full Text] [Related]
20. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]